Medical Isotope
Radiopharmaceuticals
GMP & GLP Solutions
Cancer Diagnosis & Treatment
About us
Careers
News & Events
Company News Industry Information
Contact
Language
EN CN
Home · News & Events

Industry Information

Expanded Access Program Opens in the U.S. for TLX101-CDx, Telix’s Investigational Glioma (Brain Cancer) Imaging Agent

View more
Aug 09, 2024

Blue Earth Diagnostics, a Bracco Company, Announces Results Evaluating Diagnostic Performance of POSLUMA® (Flotufolastat F 18) and Clinical Trial Enrollment in African American Men with Prostate Cancer

View more
Aug 09, 2024

Novel PET Imaging Tool Identifies Early Signs of Inflammatory Bowel Disease and Predicts Response to Treatment

View more
Aug 09, 2024

Defence Therapeutics Granted CNRI-H from the Canadian Nuclear Laboratories to Accelerate the Development of Its Radio-Immuno-Conjugates Program

View more
Aug 01, 2024

NORTHSTAR MEDICAL RADIOISOTOPES AND BWXT MEDICAL SIGN SUPPLY AGREEMENT SUPPORTING ACTINIUM-225 PRODUCTION

View more
Jul 26, 2024

FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent

View more
Jul 26, 2024
...78910111213...